WallStreetZenWallStreetZen

NASDAQ: COAG
Hemab Therapeutics Holdings Inc Stock Ownership - Who owns Hemab Therapeutics Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Hemab Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ra Capital Management LP10% Owner2026-06-1661,523$24.98
$1.54MBuy
Ra Capital Management LP10% Owner2026-06-156,146$24.89
$152.97kBuy
Ra Capital Management LP10% Owner2026-05-20996$24.94
$24.84kBuy
Ra Capital Management LP10% Owner2026-05-193,802$24.97
$94.94kBuy
Ra Capital Management LP10% Owner2026-05-126,387$24.90
$159.04kBuy
Ra Capital Management LP10% Owner2026-05-1114,149$24.47
$346.23kBuy
Ra Capital Management LP10% Owner2026-05-1125,720$25.00
$643.00kBuy
Ra Capital Management LP10% Owner2026-05-081,483$24.98
$37.05kBuy
Ra Capital Management LP10% Owner2026-05-071,985$24.95
$49.53kBuy
Ra Capital Management LP10% Owner2026-05-077,921$24.34
$192.80kBuy

1 of 2

COAG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COAG insiders and whales buy or sell their stock.

COAG Shareholders

What type of owners hold Hemab Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ai Denmab LLC10.44%4,876,344$231.48MInsider
Holdings A. Novo8.95%4,180,550$198.45MInsider
Ra Capital Management LP0.76%354,938$16.85MInsider
Mads Nikolaj Behrndteriksen0.08%36,520$1.73MInsider
John Maraganore0.08%35,948$1.71MInsider

1 of 1

COAG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COAG0.00%20.31%Net BuyingNet Buying
NUVB58.01%41.99%Net BuyingNet Buying
PGEN31.33%68.67%Net SellingNet Selling
KLRA0.00%85.31%Net BuyingNet Buying
AMLX67.16%32.84%Net SellingNet Selling
View Top Biotech Stocks

Hemab Therapeutics Holdings Stock Ownership FAQ

Who owns Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings (NASDAQ: COAG) is owned by 0.00% institutional shareholders, 20.31% Hemab Therapeutics Holdings insiders, and 79.69% retail investors. Ai Denmab LLC is the largest individual Hemab Therapeutics Holdings shareholder, owning 4.88M shares representing 10.44% of the company. Ai Denmab LLC's Hemab Therapeutics Holdings shares are currently valued at $231.87M.

If you're new to stock investing, here's how to buy Hemab Therapeutics Holdings stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.